Sheng Zhou
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Editorial expression of concern: ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 15, 2025
Efficacy of chemotherapy combined with toripalimab in PD-L1-positive and high tumor mutation burden pancreatic acinar cell carcinoma: case report.
Journal: Tumori
Published: December 21, 2020
Cholesterol activates the Wnt/PCP-YAP signaling in SOAT1-targeted treatment of colon cancer.
Journal: Cell death discovery
Published: October 30, 2020
Cholesterol metabolism: New functions and therapeutic approaches in cancer.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: June 01, 2020
Apatinib treatment for unresectable gastrointestinal stromal tumor with synchronous gastric cancer.
Journal: Precision clinical medicine
Published: December 19, 2019
Simvastatin Inhibits the Malignant Behaviors of Gastric Cancer Cells by Simultaneously Suppressing YAP and β-Catenin Signaling.
Journal: OncoTargets and therapy
Published: November 07, 2019
Inhibition of ISG15 Enhances the Anti-Cancer Effect of Trametinib in Colon Cancer Cells.
Journal: OncoTargets and therapy
Published: August 07, 2019
Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway.
Journal: Molecular cancer therapeutics
Published: April 16, 2019
The MEK inhibitors enhance the efficacy of sorafenib against hepatocellular carcinoma cells through reducing p-ERK rebound.
Journal: Translational cancer research
Published: January 22, 2019
MEK nuclear localization promotes YAP stability via sequestering β-TrCP in KRAS mutant cancer cells.
MEK nuclear localization promotes YAP stability via sequestering β-TrCP in KRAS mutant cancer cells.
Journal: Cell death and differentiation
Published: November 12, 2018
Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers.
Journal: Cancer letters
Published: May 21, 2018
ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 22, 2018
Last Updated: 09/26/2026